Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mirogabalin (DS5565) is a calcium channel blocker with analgesic effects.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 9,500 | |||
2 mg | 在庫あり | ¥ 13,500 | |||
5 mg | 在庫あり | ¥ 22,500 | |||
10 mg | 在庫あり | ¥ 33,500 | |||
25 mg | 在庫あり | ¥ 57,000 | |||
50 mg | 在庫あり | ¥ 86,500 | |||
100 mg | 在庫あり | ¥ 130,000 | |||
500 mg | 在庫あり | ¥ 282,500 |
説明 | Mirogabalin (DS5565) is a calcium channel blocker with analgesic effects. |
In vivo | Mirogabalin has potent and sustained analgesic effects (ED50 = 2.5 mg/kg) in rats with diabetes induced by streptozotocin .?Mirogabalin does not inhibit activities associated with CNS adverse effects of analgesics, such as rotarod performance (ID50 = 9.4 mg/kg) or locomotor activity (ID50 = 43.9 mg/kg), at its effective dose. |
別名 | DS5565 |
分子量 | 209.28 |
分子式 | C12H19NO2 |
CAS No. | 1138245-13-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 1.83 mg/mL (8.76 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mirogabalin 1138245-13-2 Membrane transporter/Ion channel Metabolism Calcium Channel DS-5565 DS 5565 inhibit DS5565 Inhibitor Ca channels Ca2+ channels inhibitor